Will Attention by Vaccine Developers to the Host’s Nuclear Hormone Levels and Immunocompetence Improve Vaccine Success?

Despite extraordinary advances in fields of immunology and infectious diseases, vaccine development remains a challenge. The development of a respiratory syncytial virus vaccine, for example, has spanned more than 50 years of research with studies of more than 100 vaccine candidates. Dozens of attra...

Descripción completa

Detalles Bibliográficos
Autores principales: Sealy, Robert E., Jones, Bart G., Surman, Sherri L., Penkert, Rhiannon R., Pelletier, Stephane, Neale, Geoff, Hurwitz, Julia L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466149/
https://www.ncbi.nlm.nih.gov/pubmed/30818795
http://dx.doi.org/10.3390/vaccines7010026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466149/
https://www.ncbi.nlm.nih.gov/pubmed/30818795
http://dx.doi.org/10.3390/vaccines7010026

Ejemplares similares